I*a
2 楼
因为你是康熙粉。
f*s
3 楼
尼玛 我哪是康熙粉
客观评价股票 才能学习进步！
[在 IDjia (酱油兔) 的大作中提到：]
：
：因为你是康熙粉。
：...........
客观评价股票 才能学习进步！
[在 IDjia (酱油兔) 的大作中提到：]
：
：因为你是康熙粉。
：...........
l*t
4 楼
马后炮， 技术上前面那个gap down 就该小心了，起码除掉一部分
基本面上 Akorn (AKRX -14.4%) slumps on double normal volume in response to
Actavis' (ACT -1.2%) after hours announcement of its U.S. launch of a
generic version of Fougera's Temovate (clobetasol cream 0.05%) for the
relief of inflammatory and pruritic dermatoses. Akorn's generic version was
one of its top sellers last quarter.
基本面上 Akorn (AKRX -14.4%) slumps on double normal volume in response to
Actavis' (ACT -1.2%) after hours announcement of its U.S. launch of a
generic version of Fougera's Temovate (clobetasol cream 0.05%) for the
relief of inflammatory and pruritic dermatoses. Akorn's generic version was
one of its top sellers last quarter.
l*m
5 楼
受教了
was
【在 l*********t 的大作中提到】
: 马后炮， 技术上前面那个gap down 就该小心了，起码除掉一部分
: 基本面上 Akorn (AKRX -14.4%) slumps on double normal volume in response to
: Actavis' (ACT -1.2%) after hours announcement of its U.S. launch of a
: generic version of Fougera's Temovate (clobetasol cream 0.05%) for the
: relief of inflammatory and pruritic dermatoses. Akorn's generic version was
: one of its top sellers last quarter.
was
【在 l*********t 的大作中提到】
: 马后炮， 技术上前面那个gap down 就该小心了，起码除掉一部分
: 基本面上 Akorn (AKRX -14.4%) slumps on double normal volume in response to
: Actavis' (ACT -1.2%) after hours announcement of its U.S. launch of a
: generic version of Fougera's Temovate (clobetasol cream 0.05%) for the
: relief of inflammatory and pruritic dermatoses. Akorn's generic version was
: one of its top sellers last quarter.
相关阅读